These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22314118)

  • 21. Duloxetine for the treatment of major depressive disorder in older patients.
    Nelson JC; Wohlreich MM; Mallinckrodt CH; Detke MJ; Watkin JG; Kennedy JS
    Am J Geriatr Psychiatry; 2005 Mar; 13(3):227-35. PubMed ID: 15728754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies.
    Oakes TM; Katona C; Liu P; Robinson M; Raskin J; Greist JH
    Int Clin Psychopharmacol; 2013 Jan; 28(1):1-11. PubMed ID: 23138680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2017 Jul; 71(7):. PubMed ID: 28497864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
    Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
    Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a Systematic review and meta-analysis.
    Weng C; Xu J; Wang Q; Lu W; Liu Z
    Osteoarthritis Cartilage; 2020 Jun; 28(6):721-734. PubMed ID: 32169731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat.
    Cookson J; Gilaberte I; Desaiah D; Kajdasz DK
    Int Clin Psychopharmacol; 2006 Sep; 21(5):267-73. PubMed ID: 16877897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
    Kornstein SG; Wohlreich MM; Mallinckrodt CH; Watkin JG; Stewart DE
    J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.
    Davidson J; Allgulander C; Pollack MH; Hartford J; Erickson JS; Russell JM; Perahia D; Wohlreich MM; Carlson J; Raskin J
    Hum Psychopharmacol; 2008 Aug; 23(6):519-26. PubMed ID: 18478624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2019 Oct; 73(10):e13397. PubMed ID: 31355510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials.
    Micca JL; Ruff D; Ahl J; Wohlreich MM
    BMC Musculoskelet Disord; 2013 Apr; 14():137. PubMed ID: 23590727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Jan; 68(1):60-82. PubMed ID: 24165478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lemborexant and Daridorexant for the Treatment of Insomnia: An Indirect Comparison Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed.
    Citrome L; Juday TR; Lundwall C
    J Clin Psychiatry; 2023 Oct; 84(6):. PubMed ID: 37796657
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.
    Maund E; Tendal B; Hróbjartsson A; Jørgensen KJ; Lundh A; Schroll J; Gøtzsche PC
    BMJ; 2014 Jun; 348():g3510. PubMed ID: 24899650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial.
    Beaudoin FL; Gaither R; DeLomba WC; McLean SA
    Pain; 2023 Apr; 164(4):855-863. PubMed ID: 36375173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.
    Hunziker ME; Suehs BT; Bettinger TL; Crismon ML
    Clin Ther; 2005 Aug; 27(8):1126-43. PubMed ID: 16199241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.